Changes in inflammatory biomarkers across weight classes in a representative US population: A link between obesity and inflammation

Journal of Gastrointestinal Surgery

Volumn 13, Issue 7, 2009, Pages 1205-1212

  Nguyen, Xuan Mai T ^a   Lane, John ^a   Smith, Brian R ^a   Nguyen, Ninh T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; C reactive protein; Diabetes; Fibrinogen; Hypertension; Inflammation; NHANES; Obesity

Indexed keywords

AUTACOID; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BODY MASS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; OBESITY; PROBABILITY; RISK ASSESSMENT; STATISTICAL MODEL; UNITED STATES;

ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATION; INFLAMMATION MEDIATORS; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; UNITED STATES; YOUNG ADULT;

EID: 67349226375     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-0904-9     Document Type: Article

References (38)

1. CL Ogden MD Carroll LR Curtin MA McDowell CJ Tabak KM Flegal 2006 Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 13 1549 1555 doi:10.1001/jama.295.13.1549
2. AH Mokdad ES Ford BA Bowman WH Dietz F Vinicor VS Bales JS Marks 2003 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 JAMA 289 76 79 doi:10.1001/jama.289.1.76
3. E Solá A Vayá M Simó A Hernández-Mijares C Morillas F España A Estellés D Corella 2007 Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance Clin Hemorheol Microcirc 37 4 309 318 (Pubitemid 47557214)
4. A Must J Spadano EH Coakley 1999 The disease burden associated with overweight and obesity JAMA 282 1523 1529 doi:10.1001/jama.282.16.1523
5. ES Ford WH Giles WH Dietz 2002 Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey JAMA 287 356 359 doi:10.1001/jama.287.3.356 (Pubitemid 34251969)
6. F Crummy AJ Piper MT Naughton 2008 Obesity and the lung: 2. Obesity and sleep-disordered breathing Thorax 63 8 738 746 doi:10.1136/thx.2007.086843
7. PW Wilson RB D'Agostino L Sullivan H Parise WB Kannel 2002 Overweight and obesity as determinants of cardiovascular risk: the Framingham experience Arch Intern Med 162 1867 1872 doi:10.1001/archinte.162.16.1867
8. SP Messier 2008 Obesity and osteoarthritis: disease genesis and nonpharmacological weight management Rheum Dis Clin North Am 34 3 713 729 doi:10.1016/j.rdc.2008.04.007
9. Kung HC, Hoyert DL, Xu JQ, Murphy SL. Deaths: Final Data for 2005. National Vital Statistics Reports; vol 56 no 10. Hyattsville: National Center for Health Statistics, 2008.
10. AN Vgontzas 2008 Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance Arch Physiol Biochem 114 4 211 223 doi:10.1080/13813450802364627
11. P Calabro ET Yeh 2008 Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk Curr Hypertens Rep Reb 10 1 32 38 (Pubitemid 351258847)
12. G Engstrom B Hedblad L Stavenow S Jonsson P Lind L Janzon 2004 Incidence of obesity-associated cardiovascular disease is related to inflammation- sensitive plasma proteins: a population-based cohort study Arterioscler Thromb Vasc Biol 24 1498 1502 doi:10.1161/01.ATV.0000134293.31512.be
13. GS Hotamisligil 2006 Inflammation and metabolic disorders Nature 444 860 867 doi:10.1038/nature05485
14. WB Kannel RB D'Agostino PW Wilson AJ Belanger DR Gagnon 1990 Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience Am Heart J 120 3 672 676 doi:10.1016/0002-8703(90)90026-T
15. Fibrinogen Studies Collaboration 2005 Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis JAMA 294 14 1799 1809 doi:10.1001/jama.294.14.1799
16. Pepys MB. The acute phase response and C-reactive protein. Oxford Textbook of Medicine. In Weatherall DJ, Ledingham JGG, Warrell DA, eds. New York: Oxford University Press, 1996, pp. 1527-1533.
17. RJ Bisoendial JJ Kastelein ES Stroes 2007 C-reactive protein and atherogenesis: from fatty streak to clinical event Atherosclerosis 195 2 e10 18 doi:10.1016/j.atherosclerosis.2007.04.053
18. N Rifai PM Ridker 2002 Inflammatory markers and coronary heart disease Curr Opin Lipidol 13 4 383 389 doi:10.1097/00041433-200208000-00005
19. J Danesh R Collins P Appleby R Peto 1998 Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 279 18 1477 1482 doi:10.1001/jama.279. 18.1477
20. ES Ford 1999 Body mass index, diabetes, and C-reactive protein among U.S. adults Diabetes Care 22 12 1971 1977 doi:10.2337/diacare.22.12.1971 (Pubitemid 30433974)
21. M Visser LM Bouter GM McQuillan MH Wener TB Harris 1999 Elevated C-reactive protein levels in overweight and obese adults JAMA 282 2131 2135 doi:10.1001/jama.282.22.2131
22. E Ernst 1993 Fibrinogen as a cardiovascular risk factor-interrelationship with infections and inflammation Eur Heart J 14 Suppl K 82 87 (Pubitemid 24038960)
23. AI Kakafika EN Liberopoulos DP Mikhailidis 2007 Fibrinogen: a predictor of vascular disease Curr Pharm Des 13 16 1647 1659 doi:10.2174/ 138161207780831310
24. E Solá A Vayá M Simó A Hernández-Mijares C Morillas F España A Estellés D Corella 2007 Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance Clin Hemorheol Microcirc 37 4 309 318 (Pubitemid 47557214)
25. National Center for Health Statistics. NHANES 1999-2000 Public Data Release File Documentation. Available online from: http://www.cdc.gov/nchs/data/ nhanes/gendoc.pdf [Accessed April 2008]. 2008.
26. National Center for Health Statistics. NHANES 2001-2002 Public Data Release File Documentation. Available online from: http://www.cdc.gov/nchs/data/ nhanes/nhanes-01-02/general-data-release-doc.pdf [Accessed April 2008]. 2008.
27. National Center for Health Statistics. NHANES 2003-2004 Public Data Release File Documentation. Available online from: http://www.cdc.gov/nchs/data/ nhanes/nhanes-03-04/general-data-release-doc-03-04.pdf [Accessed April 2008]. 2008.
28. Blood pressure levels. In: Heart and stroke encyclopedia: A-Z guide. Dallas, TX: American Heart Association, Available online from: http:www.americanheart.org/Heart-and-Stroke-A-Z-Guide/bplev.html 2000.
29. Centers for Disease Control and Prevention. NHANES Laboratory/Medical Technologists Procedures Manual. Atlanta, GA: Centers for Disease Control and Prevention, April 2001. Available online from: www.cdc.gov/nchs/data/nhanes/ lab1-6.pdf [Accessed April 2008].
30. National Health and Nutrition Examination Survey Laboratory Protocol for CRP and fibrinogen. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Available online from: http://www.cdc.gov/nchs/data/nhanes/frequency/lab11doc.pdf [Accessed April 2008]. 2008.
31. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 1999-2004. http://www.cdc.gov/nchs/nhanes.htm
32. Hoffman R, Benz EJ Jr, Shattil SJ, et al, eds. Hematology: Basic Principles and Practice. 4th ed. Philadelphia: Churchill Livingstone, 2005:2097.
33. McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st ed. Philadelphia: Saunders, 2007, p 239.
34. P Theuma VA Fonseca 2004 Inflammation, insulin resistance, and atherosclerosis Metab Syndr Relat Disord 2 2 105 113 doi:10.1089/met.2004.2.105
35. JP Bastard M Maachi C Lagathu MJ Kim M Caron H Vidal J Capeau B Feve 2006 Recent advances in the relationship between obesity, inflammation, and insulin resistance Eur Cytokine Netw 17 1 4 12
36. JS Yudkin CD Stehouwer JJ Emeis SW Coppack 1999 C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue Arterioscler Thromb Vasc Biol 19 972 8
37. EL Madsen A Rissanen JM Bruun K Skogstrand S Tonstad DM Hougaard B Richelsen 2008 Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study Eur J Endocrinol 158 2 179 187 doi:10.1530/EJE-07- 0721
38. E Selvin NP Paynter TP Erlinger 2007 The effect of weight loss on C-reactive protein: a systematic review Arch Intern Med 167 1 31 39 doi:10.1001/archinte.167.1.31